Further study of Hippo signaling in the context of NF2 mutation revealed that genetic and pharmacological inhibition of Yap led to decreased tumor cell proliferation and survival in NF2 mutant cells and was able to reduce schwannoma tumor growth in mouse transplant models [20]. The gene discussed is YAP1; the disease is neoplasm.